Salvage radiation therapy in prostate cancer: relationship between rectal dose and long-term, self-reported rectal bleeding

par Braide, K., Kindblom, J., Lindencrona, U., Hugosson, J., Pettersson, N.
Publié dans Clin Transl Oncol (2020)

Editorial Comment: A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

par Hugosson, J, Roobol, MJ, Månsson, M, Tammela, TLJ, Zappa, M, Nelen, V, Lott, Felipe
Publié dans Int Braz J Urol (2020)

To be screened or not to be screened? Modeling the consequences of PSA screening for the individual

par Wever, E M, Hugosson, J, Heijnsdijk, E A M, Bangma, C H, Draisma, G, de Koning, H J
Publié 2012

Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey

par Stranne, J., Axen, E., Franck-Lissbrant, I., Fransson, P., Frånlund, M., Hugosson, J., Khatami, A., Koss-Modig, K., Lodding, P., Nyberg, M., Stattin, P., Bratt, O.
Publié dans World J Urol (2019)

Quality-of-life effects of prostate-specific antigen screening

par Heijnsdijk, EAM, Wever, EM, Auvinen, A, Hugosson, J, Ciatto, S, Nelen, V, Kwiatkowski, M, Villers, A, Páez, A, Moss, SM, Zappa, M, Tammela, TLJ, Mäkinen, T, Carlsson, S, Korfage, IJ, Essink-Bot, ML, Otto, SJ, Draisma, G, Bangma, CH, Roobol, MJ, Schröder, FH, de Koning, HJ
Publié dans N Engl J Med (2012)

Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data

par Heijnsdijk, E. A. M., de Carvalho, T. M., Auvinen, A., Zappa, M., Nelen, V., Kwiatkowski, M., Villers, A., Páez, A., Moss, S. M., Tammela, T. L. J., Recker, F., Denis, L., Carlsson, S.V., Wever, E. M., Bangma, C. H., Schröder, F. H., Roobol, M. J., Hugosson, J., de Koning, H. J.
Publié dans J Natl Cancer Inst (2014)

Prostate Cancer Mortality at 11 years of Follow-up in the ERSPC

par Schröder, FH, Hugosson, J, Roobol, MJ, Tammela, TLJ, Ciatto, S, Nelen, V, Kwiatkowski, M, Lujan, M, Lilja, H, Zappa, M, Denis, LJ, Recker, F, Páez, A, Määttänen, L, Bangma, CH, Aus, G, Carlsson, S, Villers, A, Rebillard, X, Van der Kwast, Th, Kujala, PM, Blijenberg, BG, Stenman, UH, Huber, A, Taari, K, Hakama, M, Moss, SM, de Koning, HJ, Auvinen, A
Publié dans N Engl J Med (2012)

Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases

par FitzGerald, L. M., Zhao, S., Leonardson, A., Geybels, M. S., Kolb, S., Lin, D. W., Wright, J. L., Eeles, R., Kote-Jarai, Z., Govindasami, K., Giles, G. G., Southey, M. C., Schleutker, J., Tammela, T. L., Sipeky, C., Penney, K. L., Stampfer, M. J., Gronberg, H., Wiklund, F., Stattin, P., Hugosson, J., Karyadi, D. M., Ostrander, E. A., Feng, Z., Stanford, J. L.
Publié dans Prostate Cancer Prostatic Dis (2018)